Richard Sliva
Neurology · Mobile, ALNPI 1578268363
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 11.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $770, 3.8 times the $202 reported in 2023. That places this record below the midpoint for neurology clinicians in AL, where the typical reported total is $2,219.
Across 48 payments — averaging $26.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$148
- Novartis$141
- Gilead$122
- UCB, Inc.$95
- Biogen$70
- Sanofi$68
- plus $615 from 17 others
What the payments were for
- Food & beverage$1,260100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 6 | $148 |
| Novartis | 6 | $141 |
| Gilead | 1 | $122 |
| UCB, Inc. | 4 | $95 |
| Biogen | 3 | $70 |
| Sanofi | 2 | $68 |
| Genentech USA, Inc. | 3 | $68 |
| Teva Pharmaceuticals USA, Inc. | 2 | $65 |
| AbbVie | 2 | $60 |
| Upsher-smith Laboratories LLC | 2 | $47 |
| Neurocrine Biosciences, Inc. | 2 | $44 |
| Eisai Inc. | 2 | $42 |
| Neurelis, Inc. | 2 | $36 |
| Jazz Pharmaceuticals Inc. | 1 | $34 |
| Lilly USA, LLC | 2 | $31 |
| Pyros Pharmaceuticals, Inc. | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Acadia Pharmaceuticals Inc | 1 | $27 |
| SK Life Science, Inc. | 1 | $26 |
| Catalyst Pharmaceuticals, Inc. | 1 | $25 |
| Amgen | 1 | $22 |
| Grifols USA, LLC | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veklury$122
How this compares
$1,260 in reported general payments places this provider in the 40th percentile of 255 neurology providers in Alabama.
Other neurology in Mobile
- Daniel DeesMobile$799K
- Hayden LongMobile$386K
- Charles MarkleMobile$212K
- William KilgoMobile$200K
- Bassam BassamMobile$197K
- Dean NaritokuMobile$160K
- Steve CordinaMobile$69K
- Thomas FosterMobile$51K
- Laura MintoMobile$33K
- Andrew ManleyMobile$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.